Targeting the Wnt/β-catenin pathway in human osteosarcoma cells
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
// Fang Fang 1 , Ashley VanCleave 1 , Ralph Helmuth 1, 2 , Haydee Torres 1, 3 , Kirby Rickel 1, 4 , Hannah Wollenzien 1, 5 , Hongli Sun 6 , Erliang Zeng 7 , Jing Zhao 8, 9 and Jianning Tao 1, 3, 5, 10 1 Cancer Biology and Immunotherapies Group, Sanford Research, Sioux Falls, SD, USA 2 BRIN Scholar from Dakota Wesleyan University, Sanford Research, Sioux Falls, SD, USA 3 Department of Chemistry and Biochemistry, South Dakota State University, Brookings, SD, USA 4 Department of Biomedical Engineering, University of South Dakota, Sioux Falls, SD, USA 5 Basic Biomedical Sciences, University of South Dakota, Vermillion, SD, USA 6 Department of Oral and Maxillofacial Surgery, University of Iowa, Iowa City, IA, USA 7 Departments of Preventive & Community Dentistry, Biomedical Engineering, and Biostatistics, Division of Biostatistics and Computational Biology of College of Dentistry, University of Iowa, Iowa City, IA, USA 8 Population Health Group, Sanford Research, Sioux Falls, SD, USA 9 Department of Internal Medicine, University of South Dakota, Sioux Falls, SD, USA 10 Department of Pediatrics, University of South Dakota, Sioux Falls, SD, USA Correspondence to: Jianning Tao, email: Jianning.Tao@SanfordHealth.Org Keywords: osteosarcoma; Wnt/β-catenin signaling; PRI-724; Cyclin D1 Received: August 26, 2018 Accepted: November 07, 2018 Published: December 04, 2018 ABSTRACT Aberrant activation of Wnt signaling has been implicated in human osteosarcoma, which may provide a genetic vulnerability that can be targeted in osteosarcoma treatment. To test whether Wnt activation is necessary for osteosarcoma growth, colony formation, invasion, and metastasis, we treated human osteosarcoma cells with a small molecule inhibitor of Wnt/β-catenin, PRI-724, which suppresses Wnt/β-catenin-mediated transcription. We found increased protein levels of endogenous active-β-catenin in five human osteosarcoma cell lines. Treatment with PRI-724 was sufficient to inhibit human osteosarcoma 143B and SJSA-1 cell proliferation. Suppressed Wnt signaling was confirmed by decreased protein levels of the Wnt target Cyclin D1. Furthermore, we revealed significant inhibitory effects on cell migration, invasion, and colony formation in the human osteosarcoma cells. Using deposited data from next generation sequencing studies, we analyzed somatic mutations and gene expression of components in the Wnt/β-catenin pathway. We found somatic mutations and upregulated gene expression of many components in the Wnt/ β-catenin pathway, indicating activated Wnt signaling. Taken together, our results illustrate the critical role of Wnt/β-catenin signaling in human osteosarcoma pathogenesis and growth, as well as the therapeutic potential of Wnt inhibitors in the treatment of human osteosarcoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wnt/β-catenin signaling and disease
Clevers, H., & Nusse, R. (2012) · Cell · doi:10.1016/j.cell.2012.05.012 · Cited by 5,554
Dang, C. V. (2012) · Cell · doi:10.1016/j.cell.2012.03.003 · Cited by 3,390
Zhan, T., Rindtorff, N., & Boutros, M. (2017) · Oncogene · doi:10.1038/onc.2016.304 · Cited by 2,626
Mirabello, L., Troisi, R. J., & Savage, S. A. (2009) · Cancer · doi:10.1002/cncr.24121 · Cited by 2,199
WNT signaling in bone homeostasis and disease: From human mutations to treatments
Baron, R., & Kneissel, M. (2013) · Nature Medicine · doi:10.1038/nm.3074 · Cited by 2,093 · cited 1×
“Skeletal genetic studies in both humans and mice have established the Wnt/β-catenin signaling pathway as a required mechanism for osteoblast lineage determination, osteoblast differentiation, and proliferation [11, 13, 15].”
BackgroundRecurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric Osteosarcoma
Chen, X., Bahrami, A., Pappo, A., Easton, J., Dalton, J., Hedlund, E., Ellison, D., Shurtleff, S., Wu, G., Wei, L., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.003 · Cited by 752 · cited 1×
“In the past few years, several groups have performed NGS analysis on a total of 111 human OS samples and their normal tissue pairs [3, 38–43].”
BackgroundPerry, J. A., Kiezun, A., Tonzi, P., Van Allen, E. M., Carter, S. L., Baca, S. C., Cowley, G. S., Bhatt, A. S., Rheinbay, E., Pedamallu, C. S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1419260111 · Cited by 481
Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency
Kovac, M., Blattmann, C., Ribi, S., Smida, J., Mueller, N. S., Engert, F., Castro-Giner, F., Weischenfeldt, J., Kovacova, M., Krieg, A., et al. (2015) · Nature Communications · doi:10.1038/ncomms9940 · Cited by 353
Cancer stem cells in osteosarcoma
Brown, H. K., Tellez-Gabriel, M., & Heymann, D. (2017) · Cancer Letters · doi:10.1016/j.canlet.2016.11.019 · Cited by 303
Wnt signaling and cellular metabolism in osteoblasts
Karner, C. M., & Long, F. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2425-5 · Cited by 295
Zhuang, Y., Chan, D. K., Haugrud, A. B., & Miskimins, W. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108444 · Cited by 149 · cited 1×
“The value of total cell reading subtracted by the dead cell reading was considered as viable cell reading [27].”
NKD2, a negative regulator of Wnt signaling, suppresses tumor growth and metastasis in osteosarcoma
Zhao, S., Kurenbekova, L., Gao, Y., Roos, A., Creighton, C. J., Rao, P., Hicks, J., Man, T.-K., Lau, C., Brown, A. M. C., et al. (2015) · Oncogene · doi:10.1038/onc.2014.429 · Cited by 139
Cited by
Osteosarcoma mechanobiology and therapeutic targets
Shoaib, Z., Fan, T. M., & Irudayaraj, J. M. K. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15713 · Cited by 233
Human cells with osteogenic potential in bone tissue research
Dvorakova, J., Wiesnerova, L., Chocholata, P., Kulda, V., Landsmann, L., Cedikova, M., Kripnerova, M., Eberlova, L., & Babuska, V. (2023) · BioMedical Engineering OnLine · doi:10.1186/s12938-023-01096-w · Cited by 58
“Zhang R, Oyajobi BO, Harris SE, Chen D, Tsao C, Deng H-W, et al. Wnt/β-catenin signaling activates bone morpho- genetic protein 2 expression in osteoblasts.”
BackgroundStaehlke, S., Haack, F., Waldner, A.-C., Koczan, D., Moerke, C., Mueller, P., Uhrmacher, A. M., & Nebe, J. B. (2020) · Cells · doi:10.3390/cells9081784 · Cited by 36
“Other antagonistic effects on Wnt signaling in MG-63 osteoblasts, such as hypoxia [83], treatment with inhibitors of Wnt/β-catenin-mediated transcription PRI-724 [84] and Resveratrol [85] could found in other experiments.”
ResultNasser, F., Moussa, N., Helmy, M. W., & Haroun, M. (2021) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01988-x · Cited by 29
Metadata
- Authors
- Fang, F., VanCleave, A., Helmuth, R., Torres, H., Rickel, K., Wollenzien, H., Sun, H., Zeng, E., Zhao, J., & Tao, J.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2018-12-04
- Volume
- 9
- Issue
- 95
- Pages
- 36780-36792
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2903208663
- Cited by
- 69
- References
- 12
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.